Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Akcea, Ionis Announce Initiation of Trial for Amyloid Cardiomyopathy Treatment

americanpharmaceuticalreviewJanuary 16, 2020

Tag: Akcea , Ionis , ATTR cardiomyopathy , AKCEA-TTR-LRx , CARDIO-TTRansform

PharmaSources Customer Service